{"id":97981,"date":"2024-02-10T09:39:00","date_gmt":"2024-02-10T08:39:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=97981"},"modified":"2024-02-09T12:33:43","modified_gmt":"2024-02-09T11:33:43","slug":"aatec-medical-and-sprind-cooperate-in-preclinical-study","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/97981\/aatec-medical-and-sprind-cooperate-in-preclinical-study\/","title":{"rendered":"AATec Medical and Sprind cooperate in preclinical study"},"content":{"rendered":"<div class=\"entry-content\">\n<p>AATec Medical works with the active ingredient alpha-1 antitrypsin (AAT). This human serine protease inhibitor (SERPIN) protects tissue from protease damage and has both anti-inflammatory and antiviral effects. <a href=\"\/en\/day\/aatec\/\">The startup<\/a> has found a way to industrially synthesize AAT, which previously could only be produced from human blood plasma. This significantly reduces the price of the active ingredient.<\/p>\n\n\n\n<p>ATL-105 is the startup&#039;s first product candidate based on AAT and will now be further tested in collaboration with Sprind. This includes the use of so-called &quot;lung-on-a-chip&quot; models, which use human lung tissue and computer-aided simulations to study the distribution of the drug in the lungs. In this way, the partners aim to generate clinically relevant data on the drug&#039;s effects in the human lung before clinical trials begin. Sprind is supporting the testing and providing funding for the project work.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">AATec Medical aims to \u201cdevelop effective solutions to the growing global threat of respiratory diseases\u201d<\/h2>\n\n\n\n<p><strong>Sigrid Koeth<\/strong>, Innovation Manager at <a href=\"https:\/\/www.sprind.org\/de\/\" target=\"_blank\" rel=\"noreferrer noopener\">Spring<\/a>, emphasizes the importance of the project:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;With Sprind, we want to create new breakthrough innovations from Germany. The collaboration with AATec Medical is an example of our commitment to combining scientific research with entrepreneurial action and thus promoting innovative solutions in healthcare.&quot;<\/p><\/blockquote>\n\n\n\n<p><strong>Dr. R\u00fcdiger Jankowsky<\/strong>, co-founder and CEO of AATec, comments on the cooperation:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;The partnership with Sprind enables us to accelerate our research and development work and realize our innovation potential more quickly. Our goal is to utilize recombinant alpha-1 antitrypsin with state-of-the-art protein inhalation technology to develop effective solutions to the growing global threat of respiratory diseases. In addition to treating viral respiratory infections, we focus on inflammatory diseases such as COPD, asthma, acute respiratory distress syndrome (ARDS), and other respiratory diseases with high unmet medical needs.&quot;<\/p><\/blockquote>\n\n\n\n<p>AATec&#039;s technology is based on research by co-founders Dr. Manfred Stangl, Head of Kidney and Pancreas Transplantation at the University Hospital of Munich and Chief Scientific Officer of AATec, and Dr. Michael Strassmair, Head of the Department of Hand Surgery at the Manus Sana Hospital in Starnberg, Munich, and Chief Medical Officer of AATec. Last summer, the startup successfully secured its first round of financing. Unnamed private investors, industry experts, and family offices invested \u20ac2.7 million in the company.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based biotech startup AATec Medical is collaborating with the German Federal Agency for Disruptive Innovations (Sprind) on drug development. The goal of the collaboration is to test the startup&#039;s first product candidate in various disease models.<\/p>","protected":false},"author":33,"featured_media":97983,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5638,1],"tags":[4915,371,4674],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AATec Medical und Sprind kooperieren bei pr\u00e4klinischer Studie - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Biotech-Startup AATec Medical arbeitet bei der Arzneimittelentwicklung mit der Bundesagentur f\u00fcr Sprunginnovationen (Sprind) zusammen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/97981\/aatec-medical-and-sprind-cooperate-in-preclinical-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AATec Medical und Sprind kooperieren bei pr\u00e4klinischer Studie - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Biotech-Startup AATec Medical arbeitet bei der Arzneimittelentwicklung mit der Bundesagentur f\u00fcr Sprunginnovationen (Sprind) zusammen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/97981\/aatec-medical-and-sprind-cooperate-in-preclinical-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-10T08:39:00+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/\",\"url\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/\",\"name\":\"AATec Medical und Sprind kooperieren bei pr\u00e4klinischer Studie - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg\",\"datePublished\":\"2024-02-10T08:39:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"Das M\u00fcnchner Biotech-Startup AATec Medical arbeitet bei der Arzneimittelentwicklung mit der Bundesagentur f\u00fcr Sprunginnovationen (Sprind) zusammen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg\",\"width\":2400,\"height\":1602,\"caption\":\"AATec Medical\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AATec Medical und Sprind kooperieren bei pr\u00e4klinischer Studie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1602\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AATec Medical and Sprind cooperate on preclinical study - Munich Startup","description":"The Munich-based biotech startup AATec Medical is collaborating with the Federal Agency for Breakthrough Innovations (Sprind) on drug development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/97981\/aatec-medical-and-sprind-cooperate-in-preclinical-study\/","og_locale":"en_US","og_type":"article","og_title":"AATec Medical und Sprind kooperieren bei pr\u00e4klinischer Studie - Munich Startup","og_description":"Das M\u00fcnchner Biotech-Startup AATec Medical arbeitet bei der Arzneimittelentwicklung mit der Bundesagentur f\u00fcr Sprunginnovationen (Sprind) zusammen.","og_url":"https:\/\/cms.munich-startup.net\/en\/97981\/aatec-medical-and-sprind-cooperate-in-preclinical-study\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2024-02-10T08:39:00+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/","url":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/","name":"AATec Medical and Sprind cooperate on preclinical study - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg","datePublished":"2024-02-10T08:39:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"The Munich-based biotech startup AATec Medical is collaborating with the Federal Agency for Breakthrough Innovations (Sprind) on drug development.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg","width":2400,"height":1602,"caption":"AATec Medical"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/97981\/aatec-medical-und-sprind-kooperieren-bei-praeklinischer-studie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"AATec Medical und Sprind kooperieren bei pr\u00e4klinischer Studie"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":2400,"height":1602,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2024\/02\/examining-sample-with-microscope.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1744880156:24","_edit_last":"42","_yoast_wpseo_focuskw":"AATec Medical","_yoast_wpseo_metadesc":"Das M\u00fcnchner Biotech-Startup AATec Medical arbeitet bei der Arzneimittelentwicklung mit der Bundesagentur f\u00fcr Sprunginnovationen (Sprind) zusammen.","_yoast_wpseo_linkdex":"78","_thumbnail_id":"97983","wbounce_status":"default","_yoast_wpseo_primary_category":"5638","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"1","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/97981"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=97981"}],"version-history":[{"count":3,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/97981\/revisions"}],"predecessor-version":[{"id":97998,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/97981\/revisions\/97998"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/97983"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=97981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=97981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=97981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}